RE: Special Resolutions4 May 2023 16:21
Trek
If they sold IB where would that lead MS and KS? IB are running the trials. I can understand sell the imaging side off but not IB fully. Would they possibly create a new company for the trials? Is it possible this has something to do with Mike’s linked in page and Prism?
We have possibly 2 trials to finance. Surely that will need many times our mcap unless we gain significant funding from companies, government, charities etc?
IB is the jewel of IQAI, do they even mention stonechecker anymore?
Wouldn’t it make more sense to sell as a whole company ((AI and trials) to a company like Bayer that has the relevant divisions of their company already?
Sorry for the lots of questions
Thank you